跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Viatris Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 2, 2024
Approval ID
9dde0907246db675
Company
Viatris Limited
Type
Standard
Approval Details
Approval Id
9dde0907246db675
Drug Cima Aemps Name
ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89796
Holder Company Name
Viatris Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.
Holder Company Detail Path
/organization/viatris-pharma-limited
Authorization Date
2024-09-02
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Viatris Limited
Company Detail Path
/organization/viatris-pharma-limited
Company Information
Pharmaceutical Company Name
VIATRIS PHARMA LIMITED
Country Name
Hong Kong, China
City Name
sha tin,country_hk
Address
Rm A7 8/F WAH WAI INDL BLDG
Active Ingredients
LINAGLIPTINA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 2, 2024
Approval ID
9dde0907246db675
Type
Standard
Back to CIMA-AEMPS Approvals
ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
